Naughty Flicks

Skip NavigationMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenuWhat this biotech’s volatile stock price tells you about the weight loss market right nowElsa Ohlenan hour agoUniQure to seek FDA approval for Huntington’s disease gene therapy in reversalAngelica PeeblesWed, Jun 17th 2026Biotech IPO revival faces competition from cash-rich big pharma buyersElsa OhlenTue, Jun 16th 2026Centene to offer buyouts to some employees as health insurer cuts costsAnnika Kim ConstantinoMon, Jun 15th 2026Drugmakers race to find a place in the next wave of obesity drugs Angelica PeeblesSat, Jun 13th 2026Healthy ReturnsCVS Health executives on reducing healthcare’s biggest pain pointsThu, Jun 11th 2026SpaceThe space race is coming for pharma: Why drug development is heading to orbitTue, Jun 9th 2026Health and ScienceGLP-1 pioneers Novo and Lilly compete on pills, prepare to pitch seniorsTue, Jun 9th 2026Health and ScienceFood supply ‘not at risk’ after new Texas screwworm cases, USDA secretary saysMon, Jun 8th 2026Health and ScienceWeight loss drug maker sinks 23% after new safety data spooks investorsMon, Jun 8th 2026Health and ScienceAs the World Cup kicks off, health officials are focused on more than EbolaFri, Jun 5th 2026

• 1The average SpaceX buyer post-IPO is almost under water after two-day slide
• 2U.S.-Iran accord hits early snag after Swiss talks fail to proceed as planned
• 3CNBC Daily Open: Swiss signing canceled as U.S.-Iran talks stall
• 4Indian IT stocks slump up to 7% as Accenture cuts revenue outlook, fueling fresh concerns over sector growth
• 5Trump claims Iran deal is ‘unconditional surrender,’ says his power has ‘no limits’: Axios

Pharmaceuticals‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid Thu, Jun 4th 2026Health and ScienceEli Lilly’s top dealmaker says don’t be surprised to see more M&AWed, Jun 3rd 2026PharmaceuticalsWegovy weight loss pill launches in the UAE as Novo looks beyond the U.S. marketWed, Jun 3rd 2026MarketsBiotech Abivax sinks 43% as cancer cases cloud trial data for bowel disease drugWed, Jun 3rd 2026Health and ScienceLung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trialSun, May 31st 2026Health and ScienceReplimune to resubmit twice rejected drug for approval after FDA shakeupFri, May 29th 2026Biotech and PharmaInnovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billionThu, May 28th 2026Health and ScienceCVS to restore coverage of Zepbound, add Eli Lilly’s obesity pill to drug plansThu, May 28th 2026Healthy ReturnsTrump officials hit California with Medicaid funding freezeWed, May 27th 2026Healthy ReturnsHealthy Returns: Eli Lilly makes a new push into vaccines — here’s what to knowWed, May 27th 2026PharmaceuticalsEli Lilly stock edges higher as company plans nearly $4 billion in vaccine dealsTue, May 26th 2026Health and ScienceEli Lilly says next-generation weight loss drug clears crucial obesity trialThu, May 21st 2026Health and ScienceWhite House adds generic drugs to direct-to-consumer TrumpRx siteMon, May 18th 2026Health and ScienceCDC says American tests positive for Ebola in Africa, risk in U.S. remains lowMon, May 18th 2026PharmaceuticalsWeight-loss wars go global as Novo Nordisk bets big on its Wegovy pillMon, May 18th 2026AnalysisWhy J&J thinks its new psoriasis pill could be one of its biggest drugs everSat, May 16th 2026PoliticsSupreme Court allows mail-order of abortion pill mifepristone pending appealThu, May 14th 2026Health and ScienceBiogen advances Alzheimer’s drug to late-stage trial despite disappointing dataThu, May 14th 2026Health and ScienceHantavirus isn’t another Covid, but experts say it’s testing U.S. readinessThu, May 14th 2026Health and ScienceTrump says Makary resigns as FDA commissioner following backlashTue, May 12th 2026Healthy ReturnsNovo Nordisk: High-dose Wegovy caused nearly 28% weight loss in some patientsTue, May 12th 2026PharmaceuticalsHantavirus cases spark brief surge in pharma and biotech stocks — here’s why trading is so volatileMon, May 11th 2026Healthy ReturnsHealthy Returns: Novo Nordisk faces Ozempic generics in Canada Thu, May 7th 2026CNBC CuresRare disease families find roadmap to drug development at bootcampsThu, May 7th 2026

About The Author

admin

See author's posts